期刊文献+

抗髓过氧化物酶抗体IgG亚型在丙基硫氧嘧啶引起的小血管炎中的分布及其意义 被引量:10

Distribution of IgG subclass of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil induced vasculitis
原文传递
导出
摘要 目的 观察丙基硫氧嘧啶 (PTU)引起的抗中性粒细胞胞浆抗体 (ANCA)相关小血管炎患者活动期和缓解期血清中抗MPO抗体IgG亚型的分布并探讨其意义。方法 以 12例PTU引起的ANCA相关小血管炎患者为研究对象 ,收集患者未治疗的活动期血清 ,其中 10例同时具有缓解期的血清 ,应用抗原特异性ELISA法检测抗MPO抗体总IgG及各IgG亚型的滴度 ,比较其与原发性小血管炎中抗MPO抗体IgG亚型分布的异同。结果 与原发性血管炎不同 ,所有PTU引起的ANCA相关小血管炎患者血清中均未检测到IgG3亚型。其他亚型在活动期的检测结果分别为IgG1( 12 / 12例 ,10 0 % ) ,IgG2 ( 8/ 12例 ,6 6 .7% ) ,IgG4 ( 7/ 12例 ,5 8 3% ) ;缓解期各亚型的检测结果分别为IgG1( 9/ 10例 ,90 % ) ,IgG2 ( 4 / 10例 ,4 0 % ) ,IgG4 ( 2 / 10例 ,2 0 % )。与原发性小血管炎缓解期中IgG4仍保持较高水平的现象不同 ,经停用PTU及应用免疫抑制治疗病情缓解后 ,IgG4亚型的滴度显著下降甚至转阴。结论 PTU引起的抗MPO抗体IgG亚型的分布与原发性小血管炎并不一致。 Objective To investigate the distribution of IgG subclass of anti myeloperoxidase (MPO) antibodies, a kind of antineutrophil cytoplasmic autoantibody (ANCA), in sera from patients with propylthiouracil (PIU) induced vasculitis. Methods Serum samples were collected from 12 patients with PIU induced MPO ANCA positive vasculitis, both sera of active and remission phases were collected from 10 of which, and only serum of active phase was collected from 2 of which. Anti MPO IgG subclasses were detected by antigen specific ELISA. The distribution of anti MPO IgG subclasses in PIU induced vasculitis was compared with that in primary vasculitis. Results Anti MPO IgG3 subclass was not detected in the sera from both active and remission phases of PIU induced vasculitis. In the active phase the following anti MPO IgG subclasses were found: IgG1 (12/12, 100%), IgG2 (1/12, 66.7%), and IgG4 (7/12, 58.3%). In the remission phase, the following anti MPO IgG subclasses were found: IgG1 (9/10, 90%), IgG2 (4/10, 40%), and IgG4 (2/10, 20%). The titer of anti MPO IgG4 subclass remained high in the remission phase in primary vasculitis; however, it decreased significantly after the cessation of PIU use in PIU induced vasculitis. Conclusion The distribution of anti MPO IgG subclasses in the sera of the patients with PIU induced vasculitis is different from that of the patients with primary vasculitis. The higher titer pf MPO ANCA in the sera of the patients with PIU induced vasculitis may be associated with the repeated PIU stimulation.
出处 《中华医学杂志》 CAS CSCD 北大核心 2004年第19期1625-1628,共4页 National Medical Journal of China
基金 首都医学发展科研基金资助项目(2 0 0 2 3 0 18)
关键词 亚型 小血管炎 PTU ANCA IgG4 MPO 患者 高水平 目的观 期中 Propylthiouracil Vasculitis Antibodies, antineutrophil cytoplasmic Peroxidase
  • 相关文献

参考文献3

二级参考文献14

  • 1Zhao MH, Jones SJ, Lockwood CM. Bactericidal / permeability-increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol, 1995, 99: 49-56.
  • 2Zhao MH, Lockwood CM. Azurocidin is a novel antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in systemic vascutilis. Clin Exp Immunol, 1996 , 103: 397-402.
  • 3Harper L, Cockwell P, Savage CO. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant, 1998, 13: 455-458.
  • 4Miller RM, Savige J, Nassis L, et al. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves′ disease. Australas J Dermatil, 1998, 39: 96-99.
  • 5Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum, 2000, 43: 405-413.
  • 6Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol, 1997, 47:336-340.
  • 7Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet, 1993, 342: 651-652.
  • 8Wada N, Mukai M, Kohno M, et al. Prevalence of serum antimyeloperoxidase antineutrophil cytoplasmic antibodies ( MPOANCA) in patients with Graves′ disease treated with propylthiouracil and thiamazole. Endocr J,2002 ,49:329-334.
  • 9Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves′ disease. Thyroid,2000,10:595-599.
  • 10Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves′ disease treated with propylthiouracil. J Clin Endocrinol Metab, 2000,85:4270-4273.

共引文献88

同被引文献71

引证文献10

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部